These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35840661)

  • 21. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Diagnostic Assays Assisted by Micro/Nanotechnologies.
    Yue H; Huang M; Tian T; Xiong E; Zhou X
    ACS Nano; 2021 May; 15(5):7848-7859. PubMed ID: 33961413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR genetic screens to discover host-virus interactions.
    McDougall WM; Perreira JM; Reynolds EC; Brass AL
    Curr Opin Virol; 2018 Apr; 29():87-100. PubMed ID: 29684735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "CRISPR" validation of recessive brain cancer genes in vivo.
    Zuckermann M; Kawauchi D; Gronych J
    Oncotarget; 2015 Jul; 6(20):17865-6. PubMed ID: 26203775
    [No Abstract]   [Full Text] [Related]  

  • 25. The CRISPR-Cas toolbox and gene editing technologies.
    Liu G; Lin Q; Jin S; Gao C
    Mol Cell; 2022 Jan; 82(2):333-347. PubMed ID: 34968414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protocol for genome-wide CRISPR knockout screens of bacterial cytotoxins in HeLa cells.
    Yang Q; Zhou Y; He L; Zhang Y; Tao L
    STAR Protoc; 2022 Sep; 3(3):101595. PubMed ID: 35928004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR Libraries and Screening.
    Poirier JT
    Prog Mol Biol Transl Sci; 2017; 152():69-82. PubMed ID: 29150005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.
    Joung J; Konermann S; Gootenberg JS; Abudayyeh OO; Platt RJ; Brigham MD; Sanjana NE; Zhang F
    Nat Protoc; 2017 Apr; 12(4):828-863. PubMed ID: 28333914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic screens: Combining CRISPR perturbations and RNA-seq.
    Burgess DJ
    Nat Rev Genet; 2017 Jan; 18(2):67. PubMed ID: 28096529
    [No Abstract]   [Full Text] [Related]  

  • 31. CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.
    Manghwar H; Lindsey K; Zhang X; Jin S
    Trends Plant Sci; 2019 Dec; 24(12):1102-1125. PubMed ID: 31727474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deciphering, Communicating, and Engineering the CRISPR PAM.
    Leenay RT; Beisel CL
    J Mol Biol; 2017 Jan; 429(2):177-191. PubMed ID: 27916599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in therapeutic recruitment of mammalian RNAi and bacterial CRISPR-Cas DNA interference pathways as emerging antiviral strategies.
    Chin WX; Ang SK; Chu JJ
    Drug Discov Today; 2017 Jan; 22(1):17-30. PubMed ID: 27575999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PICKLES v3: the updated database of pooled in vitro CRISPR knockout library essentiality screens.
    Novak LC; Chou J; Colic M; Bristow CA; Hart T
    Nucleic Acids Res; 2023 Jan; 51(D1):D1117-D1121. PubMed ID: 36350677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput determination of in vivo DNA sequence preferences for Cas protein binding using Library-ChIP.
    Wade JT
    Methods Enzymol; 2019; 616():117-132. PubMed ID: 30691640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is Pooled CRISPR-Screening the Dawn of a New Era for Functional Genomics.
    Yao J; Dai HL
    Adv Exp Med Biol; 2018; 1068():171-176. PubMed ID: 29943304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome Editing and Its Applications in Model Organisms.
    Ma D; Liu F
    Genomics Proteomics Bioinformatics; 2015 Dec; 13(6):336-44. PubMed ID: 26762955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups.
    Song M
    Biotechnol Prog; 2017 Jul; 33(4):1035-1045. PubMed ID: 28440027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-resolution characterization of gene function using single-cell CRISPR tiling screen.
    Yang L; Chan AKN; Miyashita K; Delaney CD; Wang X; Li H; Pokharel SP; Li S; Li M; Xu X; Lu W; Liu Q; Mattson N; Chen KY; Wang J; Yuan YC; Horne D; Rosen ST; Soto-Feliciano Y; Feng Z; Hoshii T; Xiao G; Müschen M; Chen J; Armstrong SA; Chen CW
    Nat Commun; 2021 Jul; 12(1):4063. PubMed ID: 34210975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities.
    van Dongen JE; Berendsen JTW; Steenbergen RDM; Wolthuis RMF; Eijkel JCT; Segerink LI
    Biosens Bioelectron; 2020 Oct; 166():112445. PubMed ID: 32758911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.